BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 35805035)

  • 1. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.
    Li S; Pritchard DM; Yu LG
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase-2 (MMP-2): As an Essential Factor in Cancer Progression.
    Reddy RA; Sai Varshini M; Kumar RS
    Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37861020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances.
    Huang H
    Sensors (Basel); 2018 Sep; 18(10):. PubMed ID: 30262739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and metastasis.
    Kleiner DE; Stetler-Stevenson WG
    Cancer Chemother Pharmacol; 1999; 43 Suppl():S42-51. PubMed ID: 10357558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.
    Gong Y; Chippada-Venkata UD; Oh WK
    Cancers (Basel); 2014 Jun; 6(3):1298-327. PubMed ID: 24978435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
    Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
    Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
    Thakur V; Bedogni B
    Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial collagenases as markers of tumor progression.
    Brinckerhoff CE; Rutter JL; Benbow U
    Clin Cancer Res; 2000 Dec; 6(12):4823-30. PubMed ID: 11156241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
    Zhang X; Huang S; Guo J; Zhou L; You L; Zhang T; Zhao Y
    Int J Oncol; 2016 May; 48(5):1783-93. PubMed ID: 26892540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases.
    Binder C; Hagemann T; Husen B; Schulz M; Einspanier A
    Mol Hum Reprod; 2002 Sep; 8(9):789-96. PubMed ID: 12200455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
    Li X; Tai HH
    Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitors.
    Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
    Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.
    Gialeli C; Theocharis AD; Karamanos NK
    FEBS J; 2011 Jan; 278(1):16-27. PubMed ID: 21087457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer.
    Elnemr A; Yonemura Y; Bandou E; Kinoshita K; Kawamura T; Takahashi S; Tochiori S; Endou Y; Sasaki T
    Gastric Cancer; 2003; 6(1):30-8. PubMed ID: 12673424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases and their inhibitors in tumour growth and invasion.
    Kähäri VM; Saarialho-Kere U
    Ann Med; 1999 Feb; 31(1):34-45. PubMed ID: 10219712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.